Continuous Glucose Monitoring Devices: A Brief Presentation (Review)

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2022 Jan 24

PMID 35069855

Authors

Doina Andrada Mihai

Diana Simona Stefan

Daniela Stegaru

Georgiana Elena Bernea

Ileana Adela Vacaroiu

Toma Papacocea

Mircea Ovidiu Denis Lupusoru

Adriana Elena Nica

Ovidiu Stiru

Dorin Dragos

Octavian Gabriel Olaru

Affiliations

Soon will be listed here.

Abstract

As diabetes prevalence is continuously increasing, better management is needed to achieve blood glucose control, in order to prevent complications and lessen the burden of this disease. Since the first measurement of glycosuria at the beginning of the 1900s', huge advances were made in monitoring glycemia. Continuous glucose monitoring systems revolutionized diabetes management, especially for patients with type 1 diabetes. Avoiding glycemic variability and maintaining optimal glycemic control is crucial for the evolution of patients with type 1 diabetes. The usefulness of glycemic monitoring devices can be extended to patients with type 2 diabetes. It is also important to note that in those patients at risk of developing high glycemic variability (e.g. patients with advanced chronic kidney disease), continuous glycemic monitoring may improve their prognosis. These monitoring systems can be classified according to the analytical method, the degree of invasiveness, the data availability and the mode of usage. The technology is constantly improving in bioanalytical performance, biocompatibility, length of wearing time, safety and clinical features. The aim of this review was to briefly present the main characteristics of glucose biosensors, glucose monitoring systems and their clinically utility.

Citing Articles

Mind the Gap: Wearable Lactate and Glucose Monitors for Hospitalized Patients.

Guzzi J, Falter F, Kumar A, Perrino Jr A Cureus. 2025; 17(2):e78536.

PMID: 40062120 PMC: 11886925. DOI: 10.7759/cureus.78536.

Retained Continuous Glucose Monitor Sensor Wire Fragments Presenting as a Swollen Nodule of the Thigh.

Deng L, Galganski L, Krishnamurthy M JCEM Case Rep. 2025; 3(2):luae253.

PMID: 39911683 PMC: 11795673. DOI: 10.1210/jcemcr/luae253.

The Performance of Continuous Glucose Monitoring During the Intraoperative Period: A Scoping Review.

Lim H, Kim M, Kim N, Huh J, Jeong J, Hwang W J Clin Med. 2024; 13(20).

PMID: 39458119 PMC: 11508367. DOI: 10.3390/jcm13206169.

Criteria for Personalised Choice of a Continuous Glucose Monitoring System: An Expert Opinion.

Di Molfetta S, Rossi A, Boscari F, Irace C, Laviola L, Bruttomesso D Diabetes Ther. 2024; 15(11):2263-2278.

PMID: 39347900 PMC: 11467157. DOI: 10.1007/s13300-024-01654-y.

Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer.

Morgos D, Stefani C, Miricescu D, Greabu M, Stanciu S, Nica S Int J Mol Sci. 2024; 25(3).

PMID: 38339127 PMC: 10856016. DOI: 10.3390/ijms25031848.

References

Tanne J, Schafer D, Khalid W, Parak W, Lisdat F . Light-controlled bioelectrochemical sensor based on CdSe/ZnS quantum dots. Anal Chem. 2011; 83(20):7778-85. DOI: 10.1021/ac201329u. View

Didyuk O, Econom N, Guardia A, Livingston K, Klueh U . Continuous Glucose Monitoring Devices: Past, Present, and Future Focus on the History and Evolution of Technological Innovation. J Diabetes Sci Technol. 2020; 15(3):676-683. PMC: 8120065. DOI: 10.1177/1932296819899394. View

Jayakumar R, Prabaharan M, Sudheesh Kumar P, Nair S, Tamura H . Biomaterials based on chitin and chitosan in wound dressing applications. Biotechnol Adv. 2011; 29(3):322-37. DOI: 10.1016/j.biotechadv.2011.01.005. View

Timofte D, Dragos D, Balcangiu-Stroescu A, Tanasescu M, Balan D, Raducu L . Abdominal aortic calcification in predialysis patients: Contribution of traditional and uremia-related risk factors. Exp Ther Med. 2020; 20(1):97-102. PMC: 7271689. DOI: 10.3892/etm.2020.8607. View

Rock J, GERENDE L . Dextrostix method for determination of blood glucose levels. A statistical evaluation. JAMA. 1966; 198(3):231-6. View

Clarke S, Foster J . A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. Br J Biomed Sci. 2012; 69(2):83-93. View

Zhang X, Gao C, Lu S, Duan H, Jing N, Dong D . Anti-photobleaching flower-like microgels as optical nanobiosensors with high selectivity at physiological conditions for continuous glucose monitoring. J Mater Chem B. 2020; 2(33):5452-5460. DOI: 10.1039/c4tb00905c. View

Zhu Z, Garcia-Gancedo L, Flewitt A, Xie H, Moussy F, Milne W . A critical review of glucose biosensors based on carbon nanomaterials: carbon nanotubes and graphene. Sensors (Basel). 2012; 12(5):5996-6022. PMC: 3386727. DOI: 10.3390/s120505996. View

Olczuk D, Priefer R . A history of continuous glucose monitors (CGMs) in self-monitoring of diabetes mellitus. Diabetes Metab Syndr. 2017; 12(2):181-187. DOI: 10.1016/j.dsx.2017.09.005. View

10.

Danne T, Nimri R, Battelino T, Bergenstal R, Close K, DeVries J . International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 2017; 40(12):1631-1640. PMC: 6467165. DOI: 10.2337/dc17-1600. View

11.

Evans M, Welsh Z, Ells S, Seibold A . The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: A Meta-analysis of Clinical Trials and Real-World Observational Studies. Diabetes Ther. 2019; 11(1):83-95. PMC: 6965602. DOI: 10.1007/s13300-019-00720-0. View

12.

Petrie J, Peters A, Bergenstal R, Holl R, Fleming G, Heinemann L . Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetes Care. 2017; 40(12):1614-1621. DOI: 10.2337/dci17-0043. View

13.

Wadwa R, Laffel L, Shah V, Garg S . Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes. Diabetes Technol Ther. 2018; 20(6):395-402. PMC: 6110124. DOI: 10.1089/dia.2018.0150. View

14.

Bailey T, Bode B, Christiansen M, Klaff L, Alva S . The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System. Diabetes Technol Ther. 2015; 17(11):787-94. PMC: 4649725. DOI: 10.1089/dia.2014.0378. View

15.

Shichiri M, Kawamori R, Yamasaki Y, Hakui N, Abe H . Wearable artificial endocrine pancrease with needle-type glucose sensor. Lancet. 1982; 2(8308):1129-31. DOI: 10.1016/s0140-6736(82)92788-x. View

16.

Olaru O, Constantin G, Pena C . Correlations of sialic acid with glycated hemoglobin A1c and glycemia in postmenopausal women with type-2 diabetes mellitus. Exp Ther Med. 2021; 21(3):286. PMC: 7851679. DOI: 10.3892/etm.2021.9717. View

17.

Vaddiraju S, Burgess D, Tomazos I, Jain F, Papadimitrakopoulos F . Technologies for continuous glucose monitoring: current problems and future promises. J Diabetes Sci Technol. 2010; 4(6):1540-62. PMC: 3005068. DOI: 10.1177/193229681000400632. View

18.

Aggidis A, Newman J, Aggidis G . Investigating pipeline and state of the art blood glucose biosensors to formulate next steps. Biosens Bioelectron. 2015; 74:243-62. DOI: 10.1016/j.bios.2015.05.071. View

19.

Nichols S, Koh A, Storm W, Shin J, Schoenfisch M . Biocompatible materials for continuous glucose monitoring devices. Chem Rev. 2013; 113(4):2528-49. PMC: 3624030. DOI: 10.1021/cr300387j. View

20.

Vlad I, Nuta D, Ancuceanu R, Caproiou M, Dumitrascu F, Marinas I . New O-Aryl-Carbamoyl-Oxymino-Fluorene Derivatives with MI-Crobicidal and Antibiofilm Activity Enhanced by Combination with Iron Oxide Nanoparticles. Molecules. 2021; 26(10). PMC: 8158365. DOI: 10.3390/molecules26103002. View